1 | adjustment | 6,747 |
2 | adjustments | 1,179 |
3 | age-adjustment | 9 |
4 | defeathering | 5 |
5 | sr-90 | 5 |
6 | weigh-in | 5 |
7 | mb+mk | 4 |
8 | ng-min/ml | 4 |
9 | pvps | 4 |
10 | st-events | 4 |
11 | audiorecordings | 3 |
12 | dipirydamole | 3 |
13 | hplc-hrms-spe-nmr | 3 |
14 | isoflurane/n2o/lma | 3 |
15 | lpc37+cap | 3 |
16 | pancreaticodudenectomy | 3 |
17 | reduction-alone | 3 |
18 | religation | 3 |
19 | rt/adt | 3 |
20 | t-distributions | 3 |
21 | agitation/anxiety | 2 |
22 | boostering | 2 |
23 | coarctoplasty | 2 |
24 | de-flasking | 2 |
25 | declamp | 2 |
26 | deflasking | 2 |
27 | ha-treatment | 2 |
28 | mouthwashing | 2 |
29 | ni-ici | 2 |
30 | of.25 | 2 |
31 | pharyngo-oesophagectomy | 2 |
32 | propensity-weighted | 2 |
33 | reductions/delays | 2 |
34 | shift-down | 2 |
35 | subsisting | 2 |
36 | 10,874 | 1 |
37 | 10:35 | 1 |
38 | 11c-choline | 1 |
39 | 122s | 1 |
40 | 125i-iodide | 1 |
41 | 12u/kg/week | 1 |
42 | 13.3months | 1 |
43 | 1month-follow-up | 1 |
44 | 2.6-4.9h | 1 |
45 | 3.1+/-2.9 | 1 |
46 | 4-14c-e2 | 1 |
47 | 40g/l | 1 |
48 | 44.5k | 1 |
49 | 52±5days | 1 |
50 | 7,821 | 1 |
51 | 72-96h | 1 |
52 | abt/dmtu | 1 |
53 | adelphane-esidrex | 1 |
54 | administraton | 1 |
55 | admission/maximal | 1 |
56 | airemlf90 | 1 |
57 | alkali-loading | 1 |
58 | antiheparanase | 1 |
59 | ari+ltg | 1 |
60 | arthroplastics | 1 |
61 | awmd | 1 |
62 | azadiene | 1 |
63 | bonferroni-holm-correcture | 1 |
64 | cafalotin/placebo | 1 |
65 | cardio-pulmonary-bypass | 1 |
66 | cardioplegia-reperfusion | 1 |
67 | ccmf | 1 |
68 | cefoperazone-sulbactum | 1 |
69 | cispltin | 1 |
70 | codping | 1 |
71 | controls/sham | 1 |
72 | covariance-correction | 1 |
73 | cross-overing | 1 |
74 | cryoplasty.need | 1 |
75 | cswt/control | 1 |
76 | dextrin-maltose | 1 |
77 | displatin | 1 |
78 | dosing.there | 1 |
79 | drillings | 1 |
80 | ecd-db | 1 |
81 | extubation.however | 1 |
82 | facility-readiness | 1 |
83 | fec75 | 1 |
84 | gain-normalisation | 1 |
85 | gbp10 | 1 |
86 | groups.trends | 1 |
87 | ha7 | 1 |
88 | hemodyalisis | 1 |
89 | idv/adv/tiv | 1 |
90 | ifo-monotherapy | 1 |
91 | ileo-ileostomy | 1 |
92 | injection-by | 1 |
93 | interruptions/reductions | 1 |
94 | interstep | 1 |
95 | intubtion | 1 |
96 | liquid-infusion | 1 |
97 | lyophylisation | 1 |
98 | manual-screening | 1 |
99 | menopause.therefore | 1 |
100 | metforrhin | 1 |
101 | mtx-failure | 1 |
102 | ni-alloys | 1 |
103 | off-ventilator | 1 |
104 | olv/hfjv | 1 |
105 | opertion | 1 |
106 | oxygen-in-air | 1 |
107 | paching | 1 |
108 | paresthesia-steering | 1 |
109 | pbsct/hdt | 1 |
110 | peg-ifn±lamivudine | 1 |
111 | perfusion-fixation | 1 |
112 | pneumo-peritoneum | 1 |
113 | pound31 | 1 |
114 | pound788.79 | 1 |
115 | prefixation | 1 |
116 | re-perfusion | 1 |
117 | re-watering | 1 |
118 | reduction-plus-skill-building | 1 |
119 | regadenoson-as-needed | 1 |
120 | reinternalization | 1 |
121 | rifampin/isoniazid | 1 |
122 | rmet/con | 1 |
123 | rtx.we | 1 |
124 | sampling/derivatization | 1 |
125 | sm-rif | 1 |
126 | solid-removal | 1 |
127 | sonification | 1 |
128 | sroke | 1 |
129 | ssri-intake | 1 |
130 | streptozotocin-injection | 1 |
131 | stx2-treatment | 1 |
132 | surgery. | 1 |
133 | t.u.r. | 1 |
134 | tapering-off | 1 |
135 | teveten | 1 |
136 | thyroydectomy | 1 |
137 | time-adjustment | 1 |
138 | topiramat | 1 |
139 | tramadol/placebo | 1 |
140 | treatmeat | 1 |
141 | trentment | 1 |
142 | trochanterotomy | 1 |
143 | tur-b | 1 |
144 | ultrafiltrations | 1 |
145 | vaginal/abdominal | 1 |
146 | year-of-schooling | 1 |
147 | zithromax | 1 |
148 | £1.10 | 1 |
149 | £11.3 | 1 |
150 | £15.69 | 1 |
151 | £88.33 | 1 |
152 | κ-statistics | 1 |
153 | €3.30 | 1 |
1 | 10,874 | 1 |
2 | 10:35 | 1 |
3 | 11c-choline | 1 |
4 | 122s | 1 |
5 | 125i-iodide | 1 |
6 | 12u/kg/week | 1 |
7 | 13.3months | 1 |
8 | 1month-follow-up | 1 |
9 | 2.6-4.9h | 1 |
10 | 3.1+/-2.9 | 1 |
11 | 4-14c-e2 | 1 |
12 | 40g/l | 1 |
13 | 44.5k | 1 |
14 | 52±5days | 1 |
15 | 7,821 | 1 |
16 | 72-96h | 1 |
17 | abt/dmtu | 1 |
18 | adelphane-esidrex | 1 |
19 | adjustment | 6,747 |
20 | adjustments | 1,179 |
21 | administraton | 1 |
22 | admission/maximal | 1 |
23 | age-adjustment | 9 |
24 | agitation/anxiety | 2 |
25 | airemlf90 | 1 |
26 | alkali-loading | 1 |
27 | antiheparanase | 1 |
28 | ari+ltg | 1 |
29 | arthroplastics | 1 |
30 | audiorecordings | 3 |
31 | awmd | 1 |
32 | azadiene | 1 |
33 | bonferroni-holm-correcture | 1 |
34 | boostering | 2 |
35 | cafalotin/placebo | 1 |
36 | cardio-pulmonary-bypass | 1 |
37 | cardioplegia-reperfusion | 1 |
38 | ccmf | 1 |
39 | cefoperazone-sulbactum | 1 |
40 | cispltin | 1 |
41 | coarctoplasty | 2 |
42 | codping | 1 |
43 | controls/sham | 1 |
44 | covariance-correction | 1 |
45 | cross-overing | 1 |
46 | cryoplasty.need | 1 |
47 | cswt/control | 1 |
48 | de-flasking | 2 |
49 | declamp | 2 |
50 | defeathering | 5 |
51 | deflasking | 2 |
52 | dextrin-maltose | 1 |
53 | dipirydamole | 3 |
54 | displatin | 1 |
55 | dosing.there | 1 |
56 | drillings | 1 |
57 | ecd-db | 1 |
58 | extubation.however | 1 |
59 | facility-readiness | 1 |
60 | fec75 | 1 |
61 | gain-normalisation | 1 |
62 | gbp10 | 1 |
63 | groups.trends | 1 |
64 | ha-treatment | 2 |
65 | ha7 | 1 |
66 | hemodyalisis | 1 |
67 | hplc-hrms-spe-nmr | 3 |
68 | idv/adv/tiv | 1 |
69 | ifo-monotherapy | 1 |
70 | ileo-ileostomy | 1 |
71 | injection-by | 1 |
72 | interruptions/reductions | 1 |
73 | interstep | 1 |
74 | intubtion | 1 |
75 | isoflurane/n2o/lma | 3 |
76 | liquid-infusion | 1 |
77 | lpc37+cap | 3 |
78 | lyophylisation | 1 |
79 | manual-screening | 1 |
80 | mb+mk | 4 |
81 | menopause.therefore | 1 |
82 | metforrhin | 1 |
83 | mouthwashing | 2 |
84 | mtx-failure | 1 |
85 | ng-min/ml | 4 |
86 | ni-alloys | 1 |
87 | ni-ici | 2 |
88 | of.25 | 2 |
89 | off-ventilator | 1 |
90 | olv/hfjv | 1 |
91 | opertion | 1 |
92 | oxygen-in-air | 1 |
93 | paching | 1 |
94 | pancreaticodudenectomy | 3 |
95 | paresthesia-steering | 1 |
96 | pbsct/hdt | 1 |
97 | peg-ifn±lamivudine | 1 |
98 | perfusion-fixation | 1 |
99 | pharyngo-oesophagectomy | 2 |
100 | pneumo-peritoneum | 1 |
101 | pound31 | 1 |
102 | pound788.79 | 1 |
103 | prefixation | 1 |
104 | propensity-weighted | 2 |
105 | pvps | 4 |
106 | re-perfusion | 1 |
107 | re-watering | 1 |
108 | reduction-alone | 3 |
109 | reduction-plus-skill-building | 1 |
110 | reductions/delays | 2 |
111 | regadenoson-as-needed | 1 |
112 | reinternalization | 1 |
113 | religation | 3 |
114 | rifampin/isoniazid | 1 |
115 | rmet/con | 1 |
116 | rt/adt | 3 |
117 | rtx.we | 1 |
118 | sampling/derivatization | 1 |
119 | shift-down | 2 |
120 | sm-rif | 1 |
121 | solid-removal | 1 |
122 | sonification | 1 |
123 | sr-90 | 5 |
124 | sroke | 1 |
125 | ssri-intake | 1 |
126 | st-events | 4 |
127 | streptozotocin-injection | 1 |
128 | stx2-treatment | 1 |
129 | subsisting | 2 |
130 | surgery. | 1 |
131 | t-distributions | 3 |
132 | t.u.r. | 1 |
133 | tapering-off | 1 |
134 | teveten | 1 |
135 | thyroydectomy | 1 |
136 | time-adjustment | 1 |
137 | topiramat | 1 |
138 | tramadol/placebo | 1 |
139 | treatmeat | 1 |
140 | trentment | 1 |
141 | trochanterotomy | 1 |
142 | tur-b | 1 |
143 | ultrafiltrations | 1 |
144 | vaginal/abdominal | 1 |
145 | weigh-in | 5 |
146 | year-of-schooling | 1 |
147 | zithromax | 1 |
148 | £1.10 | 1 |
149 | £11.3 | 1 |
150 | £15.69 | 1 |
151 | £88.33 | 1 |
152 | κ-statistics | 1 |
153 | €3.30 | 1 |
1 | t.u.r. | 1 |
2 | £1.10 | 1 |
3 | gbp10 | 1 |
4 | €3.30 | 1 |
5 | sr-90 | 5 |
6 | airemlf90 | 1 |
7 | 7,821 | 1 |
8 | pound31 | 1 |
9 | 4-14c-e2 | 1 |
10 | £11.3 | 1 |
11 | £88.33 | 1 |
12 | 10,874 | 1 |
13 | of.25 | 2 |
14 | 10:35 | 1 |
15 | fec75 | 1 |
16 | ha7 | 1 |
17 | 3.1+/-2.9 | 1 |
18 | £15.69 | 1 |
19 | pound788.79 | 1 |
20 | isoflurane/n2o/lma | 3 |
21 | tur-b | 1 |
22 | ecd-db | 1 |
23 | regadenoson-as-needed | 1 |
24 | cryoplasty.need | 1 |
25 | propensity-weighted | 2 |
26 | rifampin/isoniazid | 1 |
27 | awmd | 1 |
28 | 125i-iodide | 1 |
29 | ssri-intake | 1 |
30 | sroke | 1 |
31 | dipirydamole | 3 |
32 | azadiene | 1 |
33 | peg-ifn±lamivudine | 1 |
34 | 11c-choline | 1 |
35 | reduction-alone | 3 |
36 | dosing.there | 1 |
37 | menopause.therefore | 1 |
38 | mtx-failure | 1 |
39 | bonferroni-holm-correcture | 1 |
40 | antiheparanase | 1 |
41 | dextrin-maltose | 1 |
42 | rtx.we | 1 |
43 | tapering-off | 1 |
44 | sm-rif | 1 |
45 | ccmf | 1 |
46 | alkali-loading | 1 |
47 | reduction-plus-skill-building | 1 |
48 | paching | 1 |
49 | mouthwashing | 2 |
50 | de-flasking | 2 |
51 | deflasking | 2 |
52 | year-of-schooling | 1 |
53 | manual-screening | 1 |
54 | codping | 1 |
55 | paresthesia-steering | 1 |
56 | defeathering | 5 |
57 | re-watering | 1 |
58 | boostering | 2 |
59 | cross-overing | 1 |
60 | subsisting | 2 |
61 | ari+ltg | 1 |
62 | 72-96h | 1 |
63 | 2.6-4.9h | 1 |
64 | ni-ici | 2 |
65 | 44.5k | 1 |
66 | 12u/kg/week | 1 |
67 | mb+mk | 4 |
68 | 40g/l | 1 |
69 | admission/maximal | 1 |
70 | vaginal/abdominal | 1 |
71 | solid-removal | 1 |
72 | ng-min/ml | 4 |
73 | cswt/control | 1 |
74 | controls/sham | 1 |
75 | pneumo-peritoneum | 1 |
76 | cefoperazone-sulbactum | 1 |
77 | teveten | 1 |
78 | weigh-in | 5 |
79 | metforrhin | 1 |
80 | displatin | 1 |
81 | cispltin | 1 |
82 | rmet/con | 1 |
83 | liquid-infusion | 1 |
84 | re-perfusion | 1 |
85 | cardioplegia-reperfusion | 1 |
86 | sonification | 1 |
87 | religation | 3 |
88 | gain-normalisation | 1 |
89 | lyophylisation | 1 |
90 | perfusion-fixation | 1 |
91 | prefixation | 1 |
92 | reinternalization | 1 |
93 | sampling/derivatization | 1 |
94 | intubtion | 1 |
95 | streptozotocin-injection | 1 |
96 | covariance-correction | 1 |
97 | opertion | 1 |
98 | administraton | 1 |
99 | shift-down | 2 |
100 | tramadol/placebo | 1 |
101 | cafalotin/placebo | 1 |
102 | lpc37+cap | 3 |
103 | interstep | 1 |
104 | declamp | 2 |
105 | 1month-follow-up | 1 |
106 | extubation.however | 1 |
107 | oxygen-in-air | 1 |
108 | hplc-hrms-spe-nmr | 3 |
109 | off-ventilator | 1 |
110 | 122s | 1 |
111 | arthroplastics | 1 |
112 | κ-statistics | 1 |
113 | groups.trends | 1 |
114 | audiorecordings | 3 |
115 | drillings | 1 |
116 | 13.3months | 1 |
117 | hemodyalisis | 1 |
118 | ultrafiltrations | 1 |
119 | interruptions/reductions | 1 |
120 | t-distributions | 3 |
121 | pvps | 4 |
122 | cardio-pulmonary-bypass | 1 |
123 | facility-readiness | 1 |
124 | adjustments | 1,179 |
125 | st-events | 4 |
126 | 52±5days | 1 |
127 | reductions/delays | 2 |
128 | ni-alloys | 1 |
129 | treatmeat | 1 |
130 | topiramat | 1 |
131 | rt/adt | 3 |
132 | pbsct/hdt | 1 |
133 | stx2-treatment | 1 |
134 | ha-treatment | 2 |
135 | trentment | 1 |
136 | adjustment | 6,747 |
137 | age-adjustment | 9 |
138 | time-adjustment | 1 |
139 | abt/dmtu | 1 |
140 | idv/adv/tiv | 1 |
141 | olv/hfjv | 1 |
142 | zithromax | 1 |
143 | adelphane-esidrex | 1 |
144 | injection-by | 1 |
145 | thyroydectomy | 1 |
146 | pharyngo-oesophagectomy | 2 |
147 | pancreaticodudenectomy | 3 |
148 | trochanterotomy | 1 |
149 | ileo-ileostomy | 1 |
150 | ifo-monotherapy | 1 |
151 | agitation/anxiety | 2 |
152 | coarctoplasty | 2 |
153 | surgery. | 1 |